Immunogenicity of Haemophilus influenzae type b polysaccharide—diphtheria toxoid conjugate vaccine in 3- to 17-month-old infants with sickle cell diseases
- 31 January 1991
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 118 (1) , 69-71
- https://doi.org/10.1016/s0022-3476(05)81847-5
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Immunization of young infants with sickle cell disease with a Haemophilus influenzae type b saccharide-diphtheria CRM197 protein conjugate vaccineThe Journal of Pediatrics, 1989
- Safety and Immunogenicity of Haemophilus influenzae Type b Polysaccharide-Diphtheria Toxoid Conjugate Vaccine (PRP-D) in InfantsThe Journal of Infectious Diseases, 1987
- Efficacy ofHaemophilus IinfluenzaeType b Polysaccharide–Diphtheria Toxoid Conjugate Vaccine in InfancyNew England Journal of Medicine, 1987
- Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of ageThe Journal of Pediatrics, 1987
- Bacteremia in sickle hemoglobinopathiesThe Journal of Pediatrics, 1986
- Safety and immunogenicity of haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of ageThe Journal of Pediatrics, 1985